Search research articles
Contact Us
Filters
Showing results (11-20 of 76) with videos related to
Page
of 8
Sort By:
MMW Fortschritte Der Medizin
|
October 20, 2004
[IRMA-pRAcs: irbesartan in the treatment of microalbuminuria and proteinuria in patients with type 2 diabetes and hypertension-prospective observational study involving 38,016 patients in the general practice setting]
H Lehnert, P Bramlage, D Pittrow, et al.
Transplantation Proceedings
|
September 2, 1998
Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need Program
E A Mueller, J M Kovarik, D Pittrow
MMW Fortschritte Der Medizin
|
December 6, 2003
[Prospective treatment study of irbesartan. Diabetic kidneys regain function]
H Lehnert, P Bramlage, D Pittrow, et al.
International Journal of Clinical Practice
|
June 30, 2010
Management of patients with peripheral arterial disease in primary care: a cross-sectional study in Germany
K Kröger, M Schwertfeger, D Pittrow, et al.
Clinical Drug Investigation
|
May 23, 2007
Regression of microalbuminuria in type 2 diabetics after switch to irbesartan treatment : an observational study in 38 016 patients in primary care
H Lehnert, P Bramlage, D Pittrow, et al.
MMW Fortschritte Der Medizin
|
August 3, 2007
[Efficacy and tolerability of pregabalin in patients with neuropathic pain. Observational study under clinical practice conditions]
R Mallison, C Tilke, M Brasser, et al.
Deutsche Medizinische Wochenschrift (1946)
|
September 1, 2009
[Pulmonary hypertension]
E Erdmann, D Pittrow, W Seeger, et al.
MMW Fortschritte Der Medizin
|
April 10, 2004
[Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients]
S K Hildemann, H M Fischer, V Bohlscheid, et al.
Fortschritte Der Medizin. Originalien
|
May 1, 2004
[Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients]
S K Hildemann, H M Fischer, D Pittrow, et al.
Deutsche Medizinische Wochenschrift (1946)
|
September 4, 2008
[Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists]
D Sander, M Schwertfeger, E Köfüncü, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 76) with videos related to
Sort By:
Page
of 8
MMW Fortschritte Der Medizin
|
October 20, 2004
[IRMA-pRAcs: irbesartan in the treatment of microalbuminuria and proteinuria in patients with type 2 diabetes and hypertension-prospective observational study involving 38,016 patients in the general practice setting]
H Lehnert, P Bramlage, D Pittrow, et al.
Transplantation Proceedings
|
September 2, 1998
Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need Program
E A Mueller, J M Kovarik, D Pittrow
MMW Fortschritte Der Medizin
|
December 6, 2003
[Prospective treatment study of irbesartan. Diabetic kidneys regain function]
H Lehnert, P Bramlage, D Pittrow, et al.
International Journal of Clinical Practice
|
June 30, 2010
Management of patients with peripheral arterial disease in primary care: a cross-sectional study in Germany
K Kröger, M Schwertfeger, D Pittrow, et al.
Clinical Drug Investigation
|
May 23, 2007
Regression of microalbuminuria in type 2 diabetics after switch to irbesartan treatment : an observational study in 38 016 patients in primary care
H Lehnert, P Bramlage, D Pittrow, et al.
MMW Fortschritte Der Medizin
|
August 3, 2007
[Efficacy and tolerability of pregabalin in patients with neuropathic pain. Observational study under clinical practice conditions]
R Mallison, C Tilke, M Brasser, et al.
Deutsche Medizinische Wochenschrift (1946)
|
September 1, 2009
[Pulmonary hypertension]
E Erdmann, D Pittrow, W Seeger, et al.
MMW Fortschritte Der Medizin
|
April 10, 2004
[Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients]
S K Hildemann, H M Fischer, V Bohlscheid, et al.
Fortschritte Der Medizin. Originalien
|
May 1, 2004
[Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients]
S K Hildemann, H M Fischer, D Pittrow, et al.
Deutsche Medizinische Wochenschrift (1946)
|
September 4, 2008
[Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists]
D Sander, M Schwertfeger, E Köfüncü, et al.
Page
of 8